Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001873905-26-000002

Chief Executive Officer sold 280,245 shares at an average $11.28 ($3,160,783)

  • Chief Executive Officer acquired 125,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tak Paul Peter Chief Executive Officer 2026-09-10 Option exercise 10b5-1 +125,000 $1.55 $193,750 393,566 D
Tak Paul Peter Chief Executive Officer 2026-09-10 Sale 10b5-1 −220,866 $11.50 $2,539,893 172,700 D
Tak Paul Peter Chief Executive Officer 2026-09-11 Sale 10b5-1 −59,379 $10.46 $620,891 113,321 D
Derivatives
Tak Paul Peter Chief Executive Officer 2026-09-10 Option exercise · Stock Option (Right to Buy) 10b5-1 −125,000 1,638,968 D
Open-market sales · 280,245 sh · avg $11.28 · $3,160,783
Loading xslF345X06/ownership.xml…